These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 1428461

  • 1. New approaches to assess topical corticosteroid bioequivalence: pharmacokinetic evaluation.
    Pershing LK.
    Int J Dermatol; 1992 Oct; 31 Suppl 1():14-20. PubMed ID: 1428461
    [Abstract] [Full Text] [Related]

  • 2. Topical 0.050% betamethasone dipropionate. Pharmacokinetic and pharmacodynamic dose-response studies in humans.
    Pershing LK, Lambert L, Wright ED, Shah VP, Williams RL.
    Arch Dermatol; 1994 Jun; 130(6):740-7. PubMed ID: 8002644
    [Abstract] [Full Text] [Related]

  • 3. Circadian activity of topical 0.05% betamethasone dipropionate in human skin in vivo.
    Pershing LK, Corlett JL, Lambert LD, Poncelet CE.
    J Invest Dermatol; 1994 May; 102(5):734-9. PubMed ID: 8176255
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Feasibility of measuring the bioavailability of topical betamethasone dipropionate in commercial formulations using drug content in skin and a skin blanching bioassay.
    Pershing LK, Silver BS, Krueger GG, Shah VP, Skelley JP.
    Pharm Res; 1992 Jan; 9(1):45-51. PubMed ID: 1589409
    [Abstract] [Full Text] [Related]

  • 6. Analysis of chromameter results obtained from corticosteroid-induced skin blanching assay: comparison of visual and chromameter data.
    Schwarb FP, Smith EW, Haigh JM, Surber C.
    Eur J Pharm Biopharm; 1999 May; 47(3):261-7. PubMed ID: 10382110
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The vasoconstrictor assay in bioequivalence testing: practical concerns and recent developments.
    Stoughton RB.
    Int J Dermatol; 1992 Oct; 31 Suppl 1():26-8. PubMed ID: 1428464
    [Abstract] [Full Text] [Related]

  • 11. Blanching activities of betamethasone formulations. The effect of dosage form on topical drug availability.
    Smith EW, Meyer E, Haigh JM.
    Arzneimittelforschung; 1990 May; 40(5):618-21. PubMed ID: 2383308
    [Abstract] [Full Text] [Related]

  • 12. Bioequivalence assessment of topical clobetasol propionate products using visual and chromametric assessment of skin blanching.
    Au WL, Skinner M, Kanfer I.
    J Pharm Pharm Sci; 2008 May; 11(1):160-6. PubMed ID: 18445371
    [Abstract] [Full Text] [Related]

  • 13. Activity of different desoximetasone preparations compared to other topical corticosteroids in the vasoconstriction assay.
    Borelli C, Gassmueller J, Fluhr JW, Nietsch KH, Schinzel S, Korting HC.
    Skin Pharmacol Physiol; 2008 May; 21(3):181-7. PubMed ID: 18523415
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Assessment of dermal bioavailability: predicting the input function for topical glucocorticoids using stratum corneum sampling.
    Pensado A, McGrogan A, White KAJ, Bunge AL, Guy RH, Delgado-Charro MB.
    Drug Deliv Transl Res; 2022 Apr; 12(4):851-861. PubMed ID: 34599470
    [Abstract] [Full Text] [Related]

  • 17. [Comparative study of the vasoconstrictive activity of preparations containing topical corticosteroids].
    Henschel V, Jaminet F.
    J Pharm Belg; 1974 Apr; 29(1):3-15. PubMed ID: 4831715
    [No Abstract] [Full Text] [Related]

  • 18. In vitro penetration through the skin layers of topically applied glucocorticoids.
    Carrer V, Alonso C, Oliver MA, Coderch L.
    Drug Test Anal; 2018 Oct; 10(10):1528-1535. PubMed ID: 29788546
    [Abstract] [Full Text] [Related]

  • 19. Analysis of chromameter results obtained from corticosteroid-induced skin blanching. I: Manipulation of data.
    Smith EW, Haigh JM, Walker RB.
    Pharm Res; 1998 Feb; 15(2):280-5. PubMed ID: 9523316
    [Abstract] [Full Text] [Related]

  • 20. Metabolism of topical drugs within the skin, in particular glucocorticoids.
    Kubota K, Ademola J, Maibach HI.
    Curr Probl Dermatol; 1993 Feb; 21():61-6. PubMed ID: 8299377
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.